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INTRODUCTION
Historically, thiamine was the first member of the
B-complex vitamins to be discovered and isolated (1).

The

term "vitamin" was originated in 1911 by Casimir Funk who
obtained a crystalline compound from rice polishings (2).
He used the word "vitamine"--an amine essential for life.
It was later shown that Funk's compound had no anti-neuritic
activity, thus it did not cure
deficiency disease.

91 beriberi, 91

the thiamine-

Between 1884 and 1912 it was deter-

mined that beriberi in man (3) and polyneuritis in birds and
rats (4) were deficiency diseases which responded to a sub
stance found in rice bran.
In 1926, Jansen and Donath (5) obtained a crystal
line substance having a high anti-neuritic activity, which
was confirmed by Eijkmann (6).
Williams (7) and Grewe (8), working independently,
showed the structure of thiamine to be as shown below:

Williams proposed the name, thiamine, after its chemical
nature as an "essential amine" and its structure having the
vital thiazole ring.

At present the terms vitamin B

1

and

thiamine are used interchangeably in America, whereas the
term aneurin is used in Europe.

2
Synthesis of thiamine was accomplished by Williams
and Cline (9) in 1936, and by Andersag and Westphal (10) in
1937.
Several investigators (11-18) have demonstrated the
participation of thiamine as the pyrophosphate ester as a
cofactor (cocarboxylase) in several enzyme systems.

They

were able to show it to be essential in carbohydrate metabolism.

The enzymes found to be involved were pyruvic de-

hydrogenase, �-ketoglutaric dehydrogenase, and transketolase
(11-16).
Gunsalus and others (19-22) demonstrated the neces
sity of thiamine in pyruvate decarboxylation.

They found

that the addition of thiamine to brain slices from thiamine
deficient animals caused an increase in oxygen uptake (cata
torulin �ffect) and an increase in carbon dioxide output.
The accumulated �-keto acids were metabolized in the pre
sence of thiamine, a buildup of the keto acids, pyruvic and
�-ketoglutaric, being a sign of thiamine deficiency.
Banerji and Yudkin (23) and Wright and Scott (14)
found that animals on low carbohydrate diets required a
smaller amount of thiamine, indicating a thiamine-sparing
effect.
Vitamin activity within the organism assumes various forms:

(1) the immediate vitamin itself,

bound form (coenzyme bound to apoenzyme),
cursors,

(2) the

(3) vitamin pre

(4) functional forms (coenzymes), and (5) cata

bolic products of vitamin metabolism.

3
Requirements for thiamine are greater than other
B vitamins because of certain factors.

First, thiamine is

not stored in the body to any significant extent; second,
thiamine is relatively more readily excreted unless it is
phorphorylated; and third, thiamine probably has other than
catalytic functions since it is required in greater than
catalytic amounts.

For example, vitamin B

12

in man is re-

quired in the amount of only a few micrograms per day,
whereas thiamine is required in the amount of �pproximately
1.5 milligrams per day.
The vitamin action of thiamine appears to be con
nected with the molecular structure (24).

The different

forms of the compound such as the hydrochloride, hydro
bromide, sulfate, etc., and the pyrophosphate ester (co
carboxylase), all demonstrate similar biological activity,
in vivo, cocarboxylase being the only actually active form.
Certain structural alterations of thiamine cause the disappearance of the vitamin activity.

Inactive forms include

thiochrome, dihydrovitamin B , oxychlorothiamine, among
1
others.

So far as is known, thiamine is the only naturally

occurring substance which exhibits vitamin B activity.
1
In addition to these compounds which exhibit vary
ing degrees of vitamin B

1

activity, there are a number of

compounds (structural analogs) which act as thiamine anta
gonists, among which, two of the most active are pyrithi
amine (PT*) (I) and oxythiamine (OT*) (II).
*In this thesis PT means pyrithiamine, OT means
oxythiamine, OTDP means oxythiamine pyrophosphate, Th
means thiamine, and TDP means thiamine pyrophosphate.

4

OH

::C

I

�:rO:�Q:

II

These two compounds have strong anti-thiamine ac
tivity, but the effect of each is manifested differently.
When PT is given to rats in a 5:1 ratio with thia
mine, they appear normal and healthy for a period of time
even longer than that for thiamine-deprived rats.

Then,

suddenly and with very little warning, the rats develop
convulsions (polyneuritis) and die within 12 to 48 hours.
In contrast to the PT-treated rats, the OT-treated animals
develop symptoms which follow quite a different pattern.
These animals appear untidy, lose their appetites, and lose
weight almost from the beginning (see Figure 1).

They

deteriorate gradually and die; death being due in part,
possibly, to inanition (25).
In an attempt to further clarify the roles of thia
mine in the mammalian organism, a number of goals were set.
These were as follows below:
(1) To determine whether or not oxythiamine pene
trated into the brain tissues was the first
goal pursued.
(2) If OT did enter the brain, the next goal
was to determine the time of maximum penetra
tion, following the administration of a single
dose.
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25).
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(3) The third goal was the determination of
localization of OT and PT, if any, and to
determine whether OT or PT had any effect on
the localization of thiamine in the brain or
in the liver.
Considering the differences in the symptoms caused
by these two antagonists, it was felt they could possibly
be used to help in the elucidation of the roles of thiamine.
There is striking contrast between the effects of pyrithia
mine and oxythiamine, namely, oxythiamine causes no symptoms of polyneuritis as does pyrithiamine.

Oxythiamine

causes the other symptoms of thiamine deficiency such as
loss of appetite, loss of weight, edema, acidosis, heart
enlargement, bradycardia, and PT. does not.

It was t�ought

that a difference might be found in the ability of the two
to enter the brain tissues.

The idea considered was that

since it is known that PT has a strong affinity for brain
tissues (26); perhaps OT, with its slower, non-neurologic
symptoms, did not enter the brain tissues.
To check this hypothesis, we utilized radioactively
labeled thiamine, oxythiamine, and pyrithiamine.
Another possibility which we considered was, should
OT also enter the brain, a difference in the localization
of the two antagonists within the tissues would be indicated.

A further idea in connection with this possibility

was that the OT and PT might have a differential effect on
the localization of the thiamine itself.
To test these possibilities, two methods were

7
attempted; the first being a radiation counting experiment,
and the second being an autoradiographic procedure.
are described in detail in the experimental section.

These

LITERATURE REVIEW
A large amount of work has been done since the dis
covery and isolation of thiamine, to clarify its function
in metabolic processes.

Its roles as a cofactor have been

established (11-19,25).

However, there are a number of

problems of thiamine function which have not been solved
(27).

An example of this is that thiamine is required in

greater than catalytic amounts (28), a fact which has yet
not been fully justified.
In addition to the fact that thiamine is required
in relatively large quantities, there is the fact that the
PT-induced deficiency manifests itself in different symp
toms than dees OT-induced deficiency (29,30).
Merrifield

Woolley and

(29) reported that OT produced all of the ty

pical signs of athiaminosis except polyneuritis, including
lowered cocarboxylase in tissues and elevated blood pyruvate levels.

Pyrithiamine, on the other hand, was found

to cause polyneuritis but no change in cocarboxylase nor
blood pyruvate levels.
De Caro (31) discovered that PT decreased the
amounts of both thiamine and thiamine diphosphate (cocar
boxylase in brain, liver, and muscle, and caused the ap
pearance of the symptoms of polyneuritis in 7-11 days,
whereas OT did not produce these same symptoms.

Steyn

Parve (32) found that OT produced no signs of athiaminosis
even after 15 days, although analysis showed significant
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decreases in thiamine diphosphate levels in heart and
breast muscle, but no significant change in liver or
brains.

The decrease in heart and breast muscle, even

then was only equivalent to that shown by animals which
had been four days on a thiamine-deficient diet.
Woolley (29) determined that by administering as
little as 20 pg of pyrithiamine per day, the effect was
cumulative, and even when thiamine was administered si
multaneously with the PT, symptoms of polyneuritis appeared
eventually, resulting in death in

8-15 days.

Oxythiamine

was found to cause death in approximately four weeks,
with none of the symptoms of polyneuritis, when administered in a ratio 25 parts OT to 1 part Th.

Gubler (28)

reported that to cause the symptoms of OT-induced athiami
nosis within approximately four weeks, an oxythiamine to
thiamine ratio of 200 to 1 was required.

Eusebi and

Cerecedo (33) demonstrated a similar effect on mice, ad
ministering OT or PT in a ratio of 50 to 1 with thiamine.
They found that PT was much more potent in that the symp
toms appeared much sooner and death occurred earlier than
with OT.
Work done by Cerecedo (34) showed that PT inhibited
the phosphorylation of thiamine in rats' livers, and Woolley
(29) demonstrated the same effect in the blood of chickens.
Pyrithiamine gave indications of having a particu
lar affinity for nervous tissue (brain), in work done by
De Caro (31), as it caused approximately 50 per cent de
crease in the amount of thiamine normally found in the

10
brain.

This was con.firmed by Rindi, Perry, and De Caro

(26), who fou.�'ld that doses e,:f 0.2 to 6 mg, alone or to
gether with small amounts of thiamine, a.· a single dose
or repeated for

4-6

days, always caused an earlier and

larger decrease of thiamine (total and TOP; content in
brain than in other organs.

This is considsred to be a

distinctive feature of PT athiaminosis as compared with
nutritional athiaminosis, where the brain is known to pre
serve its thiamine content for a longer time than do the
other organs

(26,32).

As a c.on.sequence of· this action of PT on cerebral
tissues, most animals show in 10-15 days, the typical neurological signs of beriberi.

These are difficult to pro-

duce in rodents, even in extreme nutritional thiamine de
ficiency.
A single, 1-mg dose of PT was administered in work
done by Hindi, Perry, and De Caro (26).

After 24 hours the

amount of anti-vitamin was found to decrease in the liver,
muscle, and kidneys, w,:lile it gradually increased in the
brain.

It reached, after twelve days, a level very close

to the normal thiamine level.

( See Figure 2).

A number cf specif'ic ef'fects have been noted for
both of the above-mentioned antagonists, which account,
in part, for the .symptoms which have been observed.

For

example, it has been :found that OT depresses growth {36),
and it is thought that the effect stems from inhibition
of cocarboxylase synthesis (37,38).

Oxythiamine appears

not to affect the combination of the coenzyme with apo-
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carboxylase, however.

Woolley (37) has suggested that PT

may inhibit by one or more of three mechanisms:

(1) The

antagonist interferes with the combination of thiamine
pyrophosphate (cocarboxylase) with the apoenzyme (apo
carboxylase,

(2) It competes with thiamine in the enzymatic

synthesis of cocarboxylase (i.e., pyrophosphorylation of
thiamine), or (3) The antagonist is first pyrophosphory
lated, then the pyrithiamine pyrophosphate competes with
cocarboxylase for the active site on the apoenzyme.
The effect of PT appears to be (at least in part)
directly associated with the action of thiamine pyro
phosphokinase, which is the catalytic factor involved in
transferring the diphosphate group of ATP to thiamine to
form cocarboxylase, according to the following reaction
(39) :

Enzyme
Thiamine + ATP ��======��Thiamine pyrophosphate + AMP
Oxythiamine has been found to be a competitive inhibitor of thiamine pyrophosphokinase as has PT (K.

10

=4

1.

M) (39).

=

o.85

x

The K. for OT has apparently not been de1.

termined (39).
These two antagonists have also been found by
Woolley (37), and Eusebi and Cerecedo (40) to have an in
hibitory effect on carboxylase activity when administered
in the form of their pyrophosphates.

A 77 per cent decrease

in pyruvate decarboxylation resulted in purified yeast preparations, in the presence of TDP.

Navazio (41) found

that oxythiamine inhibition in this system was dependent
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on the number of phosphate groups on the molecule, the pyro
phosphate exhibiting the greatest effect, followed by the
triphosphate, monophosphate, and the unphosphorylated oxy
thiamine, in that order.

These results were confirmed by

work reported by Velluz and Herbain (42).
Several other effects have been noted for simple
thiamine deficiency (23,43), for OT-induced deficiency (43),
and for PT-induced deficiency (43), which will not be de
fined further in this work.

EXPERIMENTAL PROCEDURE AND RESULTS
I.

MATERIALS AND METHODS
A.

Materials
1.

Unlabeled thiamine was obtained from the California Corporation for Biochemical Research
(CalBioChem); whereas the labeled product was
obtained from the Nuclear-Chicago Corporation.

2.

At first we tried to obtain labeled thiamine
hydrochloride by synthesizing the compound in
our laboratories.

The preparation of the thia

zole moiety was attempted by the method of
Williams and Ronzio (44), and it was then con
densed with 2-methyl-4-amino- 5 -chloromethyl
pyrimidine hydrochloride (a gift from Merck and
Co., Rahway, N. J.).

The resulting compound had

a specific activity of only 0.3 pc/mmole

(6.66

x

10 5 cpm/mmole), which, when injected into the
rat in amounts of about O.l mg, showed little
if any above background radiation in the animals'
brains (background = 1 5 cpm).
A second attempt was made to synthesize
the vitamin, according to the same procedure,
except that the thiourea for the second try was
labeled with sulfur-3 5 , rather than with carbon14, as was that for the first synthesis.

The

final product from this synthesis, though still
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relatively low in radioactivity, provided suf
ficient activity to make some significant de
terminations, even in the brain tissues (spe
cific activity =

17 pc/mmole).

The commercially-obtained thiamine-c

14

had a specific activity of 26.7 millicuries per
mmole, thus providing sufficient activity so
that the results were quite significant sta
tistically, thus making it possible to obtain
much more meaningful data.
3.

Unlabeled oxythiamine was obtained from CalBioChem.

The labeled compound was obtained by

converting the labeled thiamine to OT according
to the method of Rydon

(45), which consisted in

refluxing 2.0 g of thiamine hydrochloride in
100

ml of 5 � HCl for a period of 6 hours.

After refluxing, it was evaporated to dryness
under reduced pressure, and the residue was ta
ken up in 50 ml of ethanol, reevaporated to
dryness, and dissolved in 50 ml of warm methanol.

Then

75 ml of dry ether was added, and

the solution was allowed to stand to allow the
OT to crystallize.

The first run yielded

g of product, representing a

1.57

78.5 per cent yield.

In the case of the second labeled product, one
ml of

5 N HCl was added to the vial containing

the labeled thiamine, and refluxing procedure
was performed right in the vial.

After the

16
refluxing was completed, the solution was eva
porated to dryness, and the residue was dissolved
in 0.5 ml of isotonic saline solution for use.

4.

Unlabeled pyrithiamine was also obtained from
CalBioChem.

To obtain the labeled compound,

synthesis was attempted by the method of Tracy
and Elderfield (46).

However, the specific ac

tivity (3 µc/mmole) was so low as to make the
product difficult to use for the desired determinations.

Some results were obtained in the

use of the PT, but comparisons were not feasible
as differences between results were not statis
tically significant.
5.

Trichloroacetic Acid (TCA), reagent grade, was
obtained from Mallinkrodt Chemical Works.

6.

The laboratory animals used were male, Sprague
Dawley strain rats weighing between 150 and 350
grams, obtained from the Holtzmann Company,
Madison, Wisconsin.

7.

The thiamine-deficient diet, used for all ex
perimental animals, is shown in Table I.

B.

Methods
All animals were sacrificed by decapitation,
and the brain, liver, and kidneys were taken from
each animal for the determinations to be made.
1.

Counting Experiments
The organs

were homogenized in a Potter

Elvehjem homogenizer, using 15¾ TCA to extract

17

TABLE I
THIAMINE-FREE RAT DIET

Nutrient

% of Total

Wt/10 Kg

Lbs.
15.1

Sucrose

68.5

6.84 Kg

Vitamin-free casein

22.0

2.2

Corn oil

5.4

0.5

Salt mix*

4.5

o.45

ti

"
"

Vitamin mix**

22.32 g

Choline chloride

40.0

4.8
1.1
1.0

g

*Salt Mix: Caco 1200 g, Fe(C H o )•6H 0 110 g,
6 5 7
2 •7H 0 408 g,
K HP0 1290 g, KI 3.2 g,3 CaHP0 °2H 0 300 g, Mnso
4
4
2
4
2
2
ZnC1 1.0 g, NaCl 670 g, Cuso •5H o 1.2 g.
2
4
2
**Vitamin Mix: Inositol 20.0 g, Nicotinic Acid o.400
g, Pyridoxine HCl 0.060 g, Riboflavin 0.120 g, Biotin 0.002
g, Folic Acid 0.005 g, 2-Methyl-1,4-naphthoquinone 0.040 g,
£-Aminobenzoic Acid 1.000 g, Calcium pantothenate 0.600 g.
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the thiamine, oxythiamine, or pyrithiamine from
the tissues.

The homogenate was then centri-

fuged and the solid residue discarded.

The li

quid extract of each was then evaporated to dry
ness, taken up in a small volume of distilled
water, transferred to a planchet, and evapo
rated to dryness for subsequent determination
of the radioactivity present.
In early experiments it was found that
the radioactivity of the compounds utilized was
quite low, so arrangements were made to use a
more efficient counter in the Department of
Biochemistry at the University of Utah.
The thin-window counter (Tracerlab
2

model#TGC-14, window thickness 0.9 mg/cm ) in
the Brigham Young University Chemistry Depart
ment was found to count with an efficiency of
4¾, whereas the Nuclear-Chicago model# D-47
windowless counter at the University of Utah
was determined to have an efficiency of 55¾o
After obtaining and using the com
mercially-produced, highly active compound, it
became practical to use the counter in the
Brigham Young University Department of Chemistry.
a.

Oxythiamine Penetration
Three different experiments were
used to determine whether or not oxythiamine
actually entered the rats' brains,

(1) a

19
counting experiment, as decribed above, (2)
an enzymatic assay, utilizing the trans
ketolase reaction, as described below, and
(3) an autoradiographic procedure, as de
scribed under

II

e,

11

Localization Experiments.

Prior to undertaking these experi
ments, it was thought necessary to determine
that the product used was in fact oxythiamine.
To make this determination, two tests were
used.
In the procedure for the first test,
the compound prepared in our laboratory was
compared with some commercially-obtained
oxythiamine by the use of infrared and ultra
violet spectra.

These proved to be virtually

identical in each case, indicating that
essentially all of the thiamine was converted
to oxythiamine.
For the second test, we made use of
the fact that thiamine can be oxidized to
thiochrome by the action of an alkaline so
lution of potassium ferricyanide in ethanol.
The reagent used contained 0.05 part of 2.5¾
K Fe(CN) , 1 part 10% Na0H, and 2 parts 95¾
6
3
ethanol.
To perform the test, a few drops of
a known thiamine hydrochloride solution was
spotted on filter paper, and the solution
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of OT was spotted on another filter paper.
After each had been allowed to dry, the ferri
cyanide solution was sprayed on each, allowed
to dry, and checked under UV light for fluo
rescence.

The filter spotted with thiamine

showed fluorescence because of its oxidation
to thiochrome, whereas the paper spotted with
oxythiamine showed no fluorescence, since the
OT was not oxidized to thiochrome.

The oxi

dation reaction is as follows�

[OJ

N

X�x

H§)l

--.;: I

N

I

OH

c.H3

This fluorescence test for thiochrome
is quite sensitive because of the fact that the
fluorescence of the thiochrome, with the Turner
Fluorometer, is readily detectable in amounts
as low as a millimicromole.
(1) First Method--This method for the determination of oxythiamine is the same as that
described on page 16 , in which the organs
were homogenized in TCA, extracted, and
placed in planchets for counting.
(2) Second Method--This method, an enzymatic
assay, utilized the procedure of Datta and
Racker (47).
The animals were placed on a thiamine=
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:free diet for seven days, after which they
were administered 0.1 mg of OT per 100 g of
body weight.

After 24 hours they were de-

capitated, and the brains were taken and
extracted by homogenizing them in 0.33 F
HCl0 4: , and centrifuging the solid materials
down.
w�th 2

The extract was then neutralized

!

KOH to a pH of approximately 5.7.

The resulting KC10

4

was removed by centri-

i't ,gation.
To concentrate the extracts, a
rotary evaporator was utilized until the
volume was down to 1-2 ml.
These extracts were then used by
adding an aliquot to the transketolase reaction mixture.

The reason for using this

assay is that OTDP has been found to be a
potent inhibitor of the enzyme in amounts
as low as 3.6 x 10

-11

,.
M ( �7 ) .

The reaction mixture for the enzy
matic assay was prepared by adding, to a
total volume of 1.0 ml, 25 µmoles of glycyl
glycine buffer, pH 7.6; 0.47 µmole of xylu
lose-5-phosphate; not more than 0.05 µmole
of ribose-5-phosphate;

o.6

µmole of DPN;

0.2 pmole of TOP; 2 prnoles of MgC1 ; 4.5
2
pmoles of arsenate; 100 ug of glyceraldehyde3-phosphate dehydrogenase; and 0.2 unit of
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transketolase (10 units/mg) •
Inhibition of the enzyme in this
system would be indicated by a decreased
change in the absorbancy at 3qO
from DPN

+

to DPNH).

mp

(change

The reactions involved

are shown below:
transketolase

Ribose-5-P + Xylulose-5-P

Glyceraldehyde-3-P + Sedoheptulose7-P
Glyceraldehyde-3-P

+

DPN

+

glyceraldehyde-

:;:::=======:::::=::

3-P dehydrogenase
+
3-Phosphoglycerate + DPNH + H

The transketolase is required for trans

c1

ferring

and

c2

of xylulose to ribose to

produce sedoheptulose and glyceraldehyde.
The glyceraldehyde-3-phosphate is then oxi
dized to 3-phosphoglycerate by glyceraldehyde-3-phosphate dehydrogenase and DPN + ,
the DPN

+

being reduced to DPNH, which is the

basis for this assay.
(3) Third :Method--This method was an autoradio
graphic procedure, in which the animals
were submitted to the same conditions as
for the counting experiments.

However,

after sacrificing them, the organs were
prepared for slicing by imbedding them in
paraffin, slicing, and placing them on
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microscope slides.

These tissue slices were

covered with strips of X-ray film, and allowed
to set for three months before developing the
film.
This method will be described in
greater detail under "Autoradiographic Me
thod'' in the section on localization experiments.
b.

Oxythiamine Penetration with Time
After determining that OT actually pene
trated into the brain, an experiment was designed
to establish the time required after injection
to achieve maximum concentration of the compound in the brain.
The animals were prepared by placing
them on a thiamine-free diet (see Table I) for
a period of seven days prior to injecting the
compounds to be administered, in order to in
sure a high degree of penetration by the labeled material.

The compound, injected in the

amount of 0.1 mg per 100 grams of body weight,
had an activity of 1.1 x 10

6

counts per minute

per 0.1 mg.
All test animals involved were then
sacrificed at progressively longer times after
injection, the times taken being 1, 2, 3, 6, 12,
24, 36, and 48 hours.

The brain, liver, and

kidneys of each animal were collected and

extracted by the TCA method described pre
viously.
After discarding any residue, each
liquid extract was evaporated to a small
volume on a steam bath, transferred to a
planchet, and evaporated to dryness under a
heat lamp.

The thin-window counter (see

page 18) was then used to count the beta
particles emitted by the residue.
A second part to this experiment
was accomplished by placing three rats on
the thiamine-free diet, as before, after
which each animal was administered labeled
OT in the amount of 0.5 mg per day for
twelve days.

The animals were then sacri-

ficed as in previous experiments, and the
organs were removed and treated as before
to extract the OT.
The homogenate for each organ was
then treated as before so that the extract
could be placed in a planchet to enable the
radioactivity to be detected and counted.
c.

Effects of Compounds on Each Other When
Given in Combination
A further study which was carried
out in this work was the determination
of the penetration of the compounds, thia
mine, oxythiamine, and pyrithiamine into
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brain, liver, and kidneys.

In addition, a

procedure was devised to determine the ef
fect of OT or PT on the penetration of thi
amine, and the effect of thiamine on each
of the antagonists.
This study was accomplished by in
jecting 0.1 mg labeled thiamine, 0.5 mg
pyrithiamine, and 2.0 mg labeled oxythia
mine, the compounds each being administered
to a different set of rats.

Also, to other

groups, injections of compounds in combi
nation were given to each animal as follows:
(1) 0.1 mg labeled thiamine with 2.0 mg
unlabeled oxythiamine,

(2) O.l mg labeled

thiamine with 0.5 mg unlabeled pyrithiamine,
(3) O.l mg unlabeled thiamine with 2.0 mg
labeled oxythiamine, and (4) O.l mg un
labeled thiamine with 0.5 mg labeled pyri
thiamine.
These groups of animals were then
treated as for the other experiments, and
the residues of the organ extracts were
counted for radioactivity.
d.

Accounting for Total Pyrithiamine
In the results of the counting ex
periment, a discrepancy was discovered in
the total counts from pyrithiamine.

We

were able to count only a very small fraction
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of them in the brain, liver, and kidneys.
To trace the PT, the same procedure
was used as before except the urine was col
lected and extracted, and the whole body was
dissolved in concentrated nitric acid.
The urine solution was diluted to
100 ml, and a fourth of it was taken to be
evaporated to dryness.

The residue was

washed with a few ml of water which was
placed in a planchet and evaporated to dry
ness for subsequent counting,
The nitric acid solution of the
whole body was concentrated to 500 ml, and
a one-ml aliqciot taken.

This was transferred

to a planchet, dried, and the radioactivity
counted.
e.

Localization Experiments
For the localization experiments,
the time allowed after injection of the com
pounds before sacrificing the rats was de
cided on the basis of the results of the
experiment to determine the penetration time
of OT.

Our results indicated that 24 hours

after administration would be a reasonable
length of time to wait.

Although it was not

the time necessary for maximum penetration
of OT into the brain tissues, it was seen
that the amount did not increase by much

27
over the next 24 hours.
To determine localization, if any,
two methods were attempted.

The first was

quite non=specific in that it involved
three, large� generalized, approximately
equal portions of the brain; whereas the
second, an autoradiographic treatment, was
much more precise, in that it was designed
to show relatively sharp definition of
areas of radiation.
The counting experiment was ac
complished by treating the animals with
labeled thiamine, after which the animals
were sacrificed and the brains taken.

The

brains were divided into three fairly
equal portions; the frontal third, the
middle third, and the posterior third.
(All three portions are designated for the
author 0 s convenience and use, and are not
according to neuroanatomical terminology).
These three sections of the brains
were treated separately by the TCA extraction
method defined previously, and counted in
the thin-window counter.
The autoradiographic procedure is
described in the next section.
2.

Autoradiographic Method
To accomplish the autoradiographic study,
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the same type of program of diet and injections was
followed as for the counting experiments, except
that there were, in addition, two groups of rats
which were (1) administered unlabeled OT followed
by labeled thiamine, and (2) unlabeled PT followed
by labeled thiamine.

The brain, liver, and kidneys

of each animal were treated according to the follow
ing scheme (48):
a.

The organs were carefully removed, tied in gauze
bags (to facilitate handling), and soaked in
formaldehyde solution (ca. 4%) for two days.

b.

Following the formaldehyde treatment, the or
gans were transferred to 70% ethanol solution
for approximately 12 hours.

c.

This was followed by two half-hour baths in

95% ethanol.
d.

The 95% ethanol baths were followed by two
half-hour baths in absolute ethanol.

e.

After the absolute ethanol baths, there fol
lowed a 12-hour bath in chloroform for the
brains; three hours for the other organs.

f.

After the appropriate length of time in chloro
form, paraffin chips were added to the chloro
form, and it was allowed to stand for a length
of time identical with that in the chloroform
alone.

g.

Following the chloroform-paraffin bath, the
organs were placed in melted paraffin for one-
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half hour, and transferred to,fresh, melted
paraffin, again for one-half hour.
h.

Finally, the organs were placed in a tray and
covered with melted paraffin, and allowed to
cool for at least 24 hours.
The paraffin blocks, each containing
a portion of an organ, were then cut out and
placed on wooden blocks so that they could be
sliced with a microtome.
The slides were then prepared and the
X=ray film (Kodak PFG 470 Photoflure, green
sensitive) applied for exposure to the radiation
present in the tissue slices on the slides.
(All film handling was done in complete dark
ness because of the sensitivity of the film to
all wavelengths of visible light).

These were

prepared so that there were several small
groups to be developed at successively longer
times, beginning at four weeks, and each two
weeks thereafter, to determine the optimum
exposure time for the autoradiographic deter
mination.
i.

Method of Determination
In order to utilize the autoradio
graphic method, a system was devised to deter
mine whether or not there was any localization
occurring in the brain or the liver, of OT
or thiamine; or if the administration of OT

30
or PT along with thiamine had any effect on the
localization of thiamine itself.
Labeled thiamine and OT were each ad
ministered for the purpose of determining the
difference in localization of the two, if any.
For the determination certain relatively large
general areas of the tissue slices were examined
under the microscope by first finding an area on
each tissue slice, then refocusing on the auto
radiographic

11

picture 11 and counting the silver

grains, which represent the disintegrations from
the C-14.

The background radiation was determined

by counting the grains in an area not located
directly above a tissue slice.

The areas were

located by use of a rat brain atlas prepared by
de Groot (49).
For faster counting, an ocular grid, one
square centimeter divided into 100 square milli
meters, was used.

(A graphic illustration of

the film and slide setup, and the counting me
thod are shown in Figures 3 and 4).
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II.

EXPERIMENTAL RESULTS
A.

Oxythiamine Penetration
It was quite evident, even with the OT of
low specific activity, that this compound entered
the brain.

It was later determined by detection

of the radioactivity in two different sets of test
animals, that the OT penetrated into the brain in
detectable amounts.

In Table II are recorded the

results of the counting experiments which showed
the presence of OT in the brain tissues.
Also in Table II it can be noted that the
blood taken from the whole rat yielded only from
one-third to one-sixth as much radioactivity as
was detected in the brain.

Thus the small amount

of blood that might have been extracted with the
brain tissues could not account for the activity
detected therein.
B.

Transketolase Assay
The results of this experiment were in
conclusive in that the differences between con
trol and sample were insignificant (see Table III).
Two possibilities present themselves with
respect to these data.

These are as follows:

(1)

Eit�er no oxythiamine pyrophosphate was formed in
the brain, or (2) an insignificant amount of OT
entered the brain.
Some inhibition was indicated; however, it
was just as great for the control as it was for
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TABLE II
COMPARISON OF RADIOACTIVITY
IN BLOOD* AND BRAIN

Sample

No. Rats

CPM (Total)

CPM (Net)
Background (:Mean + s d Q)
Ii)

21.2

= 5.32

Brain PT

8

53.7

OT

8

71.2

II

60.0 .12.7

Th

8

52.2

II

31.0

=

3.24

Blood PT

4

27

II

5.8

±

1.96

II

OT

2

34.3

II

Th

4

31.6

II

"

"
"

32.5

13.1

,.

1.3

10.4 ± 2.07

*The values shown represent the counts per minute ex
tracted from the blood from a ,.,-hole animal.
This indicated
the amount of blood which might have remained and been extract
These results
ed with the brain tissues to be quite small.
show the possibility of only relatively few of the counts com
ing from the blood in the brain.
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TABLE III
TRANSKETOLASE ASSAY

Assay
1

2
3

Sample

5
6

OT

7
8
9
10
11
12

"
"
"
"

II

pH at End
7.5

0.222

7.52

0.05

0.192

7.53

0.10

0.163

7.50

0.15

0.145

7.55

0.05

0.177

7.52

0.10

0.153

7.52

0.15

0.141

7.52

0.05

0.184

7.50

0.10

0,158

7.56

0.15

0.135

"

Control

LiA/Min.
0.213

Blank

"
"

4

Ml. Inhib.

No TDP 0.0042

7.52
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the samples from the treated animals.
C.

Oxythiamine Penetration with Time
In consequence of the conclusion that OT
does enter the brain tissues, it was felt that a
determination of the rate and extent of the pene
tration should be attempted.
The analysis was done, again by the use
of labeled compounds.

It was discovered that a

significant number of counts could be detected in
the brain even after an hour following a subcutane=
ous injection.

The radioactivity increased rapidly

from one to six hours, after which the increase
was not so rapid between 24 and 48 hours after the
single 0.2 mg dose was administered.

(See Table IV

and Figure 5.)
In the liver and kidneys the radioactivity
decreased.

As can be seen from Figure 5, the de

crease was quite rapid in the liver for the first
six hours, then it tended to level off to a gradual
decline.

In the kidneys the decline was relatively

gradual from the first hour on.
The values seen in Table IV at one hour
show 2320 counts per minute which represent 5.12
pg OT in the liver, 559 counts per minute which
represent 1.23 pg OT in the kidneys, and 221 counts
per minute, representing

o.49

pg OT in the brain.

After 48 hours the counts per minute had changed to
1280 (2.82 pg) in the liver, 380 (0.84 pg) in the
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TABLE IV
PENETRATION OF OXYTHIAMINE INTO
TISSUES WITH TIME

Time (Hr.)

No.
Animals

Radioactivitr in Tissues (CPM)
Kidneys
Brain
Liver

1

4:

2320 :t:32.7

559 :t::17

221 ± 3.8

2

4

2290 !!4:5

588 :t:4:5

328

3

4

1900 ±29

4:74: :t:18

365 :1::16.3

6

4

1590 *57

580 :t:32.6 390 ± 1.7

12

4

1570 ±17

4:74:

24:

6

1380 :t:28.6

450 :t:11.5 727 :t:: 9.6

36

4

1320 :i:30.6

435 ±14.4: 720 ± 6.5

48

4:

1280 �1 7

380

:I:

:1:

9

:t:

4:.5

524 :i: 3.6

9.8 822 :i:32.2
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kidneys, and 822 (1.81 pg) in the brain.
In the further experiment, treating the
animals with 0.5 mg OT per day for 12 days, we
found the liver to have much lower activity than
at 48 hours, the kidneys were near the same level
as before, and the brain amount had apparently
leveled off at about 1100 counts per minute (2.5 pg).
(See Table V for results).
TABLE V
OXYTHIAMINE LEVELS AFTER TWELVE DAYS

Ave CPM

Sample*

pg Amts

Liver

129

0.33

Kidneys

729

l.82

1065

2.66

Brain

*Each value represents 3 samples.
D.

Effects of Compounds on Each Other When Given in
Combination
Injection of combinations of the compounds
resulted in a decrease of thiamine in liver by
both OT and PT, and an increase in both brain and
kidneys for each antagonist.

These differences

are relative to the amount indicated when thiamine
was administered by itself.
Oxythiamine showed a decrease in both
brain and kidneys when injected along with thiamine,
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and pyrithiamine showed a decrease in brain tissues
when administered with thiamine, when compared with
amounts of compounds when administered by them=
selves.
The pyrithiamine differences seen in liver
and kidneys were not significant when tested statistically.

All of the other pertinent differences

showed a high degree of significance (P = 0.01)
when submitted to the "t" test (50).

See Table

VI and Figure 6 for an illustration of the results.
To compare the results obtained from the
use of the compounds of low specific activity with
those from the use of the highly active compounds,
see Table VII.
This table also shows the microgram
amounts which were extracted from the various
tissues.
Table VII

indicates that a minute amount

of the pyrithiamine administered could be accounted
for in the organs checked.

However, we found by

checking the urine and the whole body that we could
account for essentially all of it.
Our results indicated that approximately
7500 counts per minute were somewhere in the rest
of the body.

The urine contained approximately

125 counts per minute.
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TABLE VI
ORGAN PENETRATION OF THIAMINE
OXYTHIAMINE� AND PYRiTHIAMINE j AND
EFFECT OF INJECTING COMPOUND COMBINATIONS

Sample De5cription

No.
Animals

Ave. CPM
(Mean + 5.d.)

8
8
8
8
8
8
8

31.0 :1:: 3.24
77 • If: ± 6.91
53.3 ± 3 • 1i9
60.0 ±12.7
17.o ± 3.27
35.4 :1: 3.78
21.6 ± 3.06

4
4
3
4
4
3
3

61.1
51.0
21.6
28.3
39.8
6.6
3.0

4
4
4
2
4
4
4

21.2
43.6
58 .. 7
70.6
20.1
4.6
13.0

Brain (labeled Th)
(labeled Th, unlabeled OT)
(labeled Th, unlabeled PT)
(labeled OT)
(labeled OT, unlabeled Th)
(labeled PT)
(labeled PT, unlabeled Th)
Liver (labeled Th)
(labeled Th, unlabeled OT)
(labeled Th, unlabeled PT)
(labeled OT)
(labeled OT, unlabeled Th)
(labeled PT)
(labeled PT, unlabeled Th)
Kidneys

(labeled Th)
(labeled Th, unlabeled OT)
(labeled Th, unlabeled PT)
(labeled OT)
(labeled OT, unlabeled Th)
(labeled PT)
(labeled PT, unlabeled Th)

±18.2
±11.2
± 9.6
* 2.91
± 8.3
± 1.55
± 1.67
3.71
± 3.5
± 8.5
:I:

± 2.01
± 0.94
± 1.55
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Fig. 6.
Comparison of Results of Three Tissues
when one or more compounds were injected simultaneously.
1. Labeled Th, 2. Labeled Th with unlabeled OT, 3. Labeled
Th with unlabeled PT, 4. Labeled OT, 5. Labeled OT with
unlabeled Th, 6. Labeled PT, 7. Labeled PT with unlabeled
Th.

E.

Localization Experiments
1.

Counting Experiment
The results of the counting showed a
larger amount of OT concentrated in middle
third of the brain.

(See Table VIII).

How-

ever, it also indicated the same type of re
sults for PT.
This procedure was performed on the
"spur of the moment" and primarily to give an
indication of the localization of OT, if any,
and was not intended to furnish quantitative
data.
2.

Autoradiographic Experiment
a.

Preliminary Results
The first group of slides which
were developed (3 mos. exposure) indi
cated no apparent localization of either
thiamine or oxythiamine.

However, the

autoradiographs were so faint as to make
definite conclusions impossible.

Rather

they indicated the necessity for perhaps
four to eight weeks more exposure of the
film to the tissue slices before satis
factory results could be expected.
In an attempt to count the grains
on the above-mentioned slides it was dis
covered, after counting a half-dozen of
them, that the exposed areas were essen-

TABLE VII I
LOCALIZATION OF OXYTHIAMINE AND PYRITHIAMINE
IN RATS' BRAINS

De.scription
OT (Frontal third)

"
"

(Middle third)
(Po.sterior third)

PT (Frontal third)

"
"

Time £or 3000 Count.s

14 • .30 min.
6.34
15 • .31
14 • .38

(Middle third)

10.24

(Posterior third)

19.01

"
"

II

"
"

CPM (Ave.)*

214
477
207
210
294
174

*Each value is the average 0£ only two samples.
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tially indistinguishable from background, even
though the shadow could be seen, very faintly,
with the naked eye.

On the average, both the

exposed areas and background radiation �esulted
in about 175 grains being counted.

(Refer to

Figure 4 for areas counted). Counting was done
using the oil immersion lens of the microscope,
without oil.
b.

Final Results
The second set of autoradiographs were
much better than the first in that the radiation
image was much more vivid.
Again an attempt was made to count the
exposed grains of the emulsion on the film.

The

results left much to be desired in accuracy and
statistical significance.

The main problem was

in the fact that it was next to impossible to
visually assign a grain size to represent one
disintegration, and to extrapolate to a value
for the various large spots involving a vari
able number of single disintegrations.

There

fore, an alternate, though still not quanti
tative, system was decided upon.

This in

volved nothing more than having the radiation
exposed "negative" printed on photographic
paper (see Figure 7).
It is apparent in the "picture" that
some areas are darker than others.

(In this
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case the lighter areas represent the more
heavily exposed portions of the film).
The most heavily cross-hatched areas
in Figure 8 indicate the areas which apparently
contained the heaviest concentrations of thiamine.

The lightest area indicates the area of

lowest concentration.

It was not possible to

distinguish smaller structures on the auto
radiographs.
It appears that the highest concentra
tion of radioactivity has occurred in the gray
matter, which includes the cerebral cortex and
what appears to be the thalamus.
Photographic prints were prepared for
the slides from the animals which had been
treated with the combinations, labeled thia
mine and unlabeled oxythiamine, and labeled
thiamine and unlabeled pyrithiamine.

It

would have been well to have prints from the
OT-treated animals; however, the autoratio
graphs were so faint as to make a photographic
print nearly impossible, because of the lack
of contrast.
The fact that the image on the auto
radiograph was so faint, considering the fact
that the OT amount was equivalent to the amount
of thiamine injected, again gives an indication
that less OT enters the brain than does thiamine.

Figure'?. Photographic prints made from the autoradiograohs·
produced by the radiation from carbon-14 in the thiamine molecules which
were administered subcutaneously. (Notice the various shades of gray
in different areas of the "picture. 11)

Hippocampus

Thalamus

Figure 8. Schematic representation of an autoradiograph, show
ing the different areas apparent. The more heavily cross-hatched areas
represent the areas in which the most radiation was apparent on the film.
Conversely, the lighter areas are those which apparently had the lowest
concentration of radioactivity. The corpus callosum, the lightest area
on the film, apparently concentrates very little thiamine--it can be
seen on the prints in figure 7 as a dark line. The darkest areas are the
thalamus (in the center) and the cerebral cortex (around the outside).
Apparently the gray matter collects thiamine to a greater extent than
does the white matter.

DISCUSSION
A large amount of work has been done to determine
more fully the functions of thiamine.

However, there is

much yet to be accomplished.
The work represented by this thesis has been an
attempt to utilize the two powerful thiamine antagonists,
oxythiamine and pyrithiamine, to draw some further con
clusions about the metabolic roles played by the vitamin.
In this study, labeled compounds have been uti
lized to study the penetration and localization of the vi
tamin as well as the antagonists.
The observation has been previously made that pyri
thiamine-induced thiamine deficiency resulted in the mani
festation of entirely different symptoms from those shown
by the animal with oxythiamine-induced athiaminosis.

It

was apparent that the two antagonists affected the orga
nism differently, which indicated that thiamine must have
more than one role in the animal.
We felt that perhaps a difference in the penetra
tion of the two antagonists into brain tissue and/or a
difference in the localization of the two in the tissues
would help to explain the different symptoms manifested.
In addition, an attempt was made to determine whether the
administration of either of the antagonists had an effect
on the localization of thiamine itself.
As has been mentioned previously in this thesis,

a number of workers (29-35) have demonstrated the strong
affinity of pyrithiamine for nervous tissue.

However, it

had not previously been reported whether or not oxythiamine
entered the brain.

Again, a difference in the two compounds

in this respect, we thought, might help to explain the dif
ferences in the symptoms caused by the two antagonists,
pyrithiamine and oxythiamine, which would therefore indicate
more strongly the modes of thiamine action.
Rindi and his coworkers (51) have recently reported
that OT did not enter the brain except perhaps in very small
amounts.

They admitted that their analysis was not good in

OT amounts of less than

o.49

pg per gram of tissue.

Our

system has shown the presence of relatively small amounts
of OT in the brain tissues, and indicated a concentration
of approximately 0.25 ug OT per gram of tissue.
It is not clear from our results whether the amounts
detected were physiologically important.

However, the fact

that the compound entered the brain in detectable amounts
is enough to complicate the analysis of the physiologic
effects of oxythiamine and pyrithiamine.
A second part to this experiment, a determination
of the effects on the permeability of the compounds when
given in various combinations, was undertaken and the re
sults (see Table VI) indicated only that when either OT or
PT was administered with thiamine, the amount of thiamine
entering the brain or the kidneys was increased more than
when thiamine was given by itself.

At the same time, the

counts due to oxythiamine or pyrithiamine, when administered
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with thiamine, appeared to decrease.
Our autoradiographic determinations, as well as the
counting experiments, have shown the penetration of oxythi
amine into the brain tissueso

No distinctively different

localization has been indicated for thiamine when the ani
mal was subjected to OT or PT from the localization inci
cated for thiamine alone.

Figures 7 and 8 show the apparent

localization pattern for thiamine in a transverse section
of the braino
It appears that thiamine is concentrated more strong=
ly in the areas of the cerebral cortex and the thalamus
(gray matter), and the least in the white matter, especial
ly in the vicinity of the corpus callosum.

SUMMARY AND CONCLUSIONS
Because of the different symptoms manifested in
animals treated with pyrithiamine from those manifested by
animals treated with oxythiamine, it seems probable that
thiamine has more roles than as merely a coenzyme for
carboxylase, transketolase, pyruvic dehydrogenase, and
��ketoglutaric dehydrogenase.
This work has been an attempt to determine reasons
for the different manifestations, and thereby help to clari
fy the functions of thiamine in animal metabolism.
Our work has shown that oxythiamine, as well as
We have also determined a

pyrithiamine enters the brain.

time course of penetration of oxythiamine into the brain,
liver, and kidneys.

This study has shown that the oxy

thiamine content of the brain, at least in thiamine-de
ficient animals, increased in a manner similar to that of
pyrithiamine (26) for a period of

48

hours, and that the

amount in the liver decreased rapidly for the first 6
hours, after which the decline became more gradual.

In

the kidneys it appeared that the amount of oxythiamine was
quite constant over a period of

48

hours, with only a gra

dual decrease over that period of time.
In the experiment in which we administered labeled
OT daily for 12 days, the results indicated a leveling off
of the OT amount in the brain and kidneys, with quite a
large decrease in the liver.

After the 12 days the brain
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had apparently leveled off at an OT content of about 2.6 pg,
the kidneys remained at about 1.8 pg, and the liver dropped
off to about 0.3 pg.
the brain.

Again it is evident that OT entered

However, these results do not indicate whether

or not the amount of OT in the brain is physiologically
important.
Autoradiography, while not quantitative, has also
shown that OT entered the brain tissues.

This of course

did not indicate the amount, or whether the amount was
significant physiologically.
This same technique has now shown that some areas
of the brain seem to collect more thiamine than others.
However, it was not apparent that OT or PT had any effect
on the localization of thiamine.
From this work it is apparent that there is yet a
considerable amount of work to be done before the meta
bolic functions of thiamine can be completely elucidated.
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ABSTRACT
To investigate the possibility that thiamine has
more than one vital role in the mammalian system, it was de
cided to use the antagonists pyrithiamine and oxythiamine,
and to utilize carbon-14 labeled compounds to more effect
ively study the vitamin and the above-named antagonists.
To make it more effective, we felt that perhaps
differences between the localization of oxythiamine and
pyrithiamine could be detected in the brain.

We also con

sidered and tested the possibility that either or both of
the antagonists would alter the localization of thiamine.
Essentially, two procedures were used in this study.
One was a counting method and the other an autoradiographic
study.

The counting method was used to determine whether

or not the brain was permeable to oxythiamine, as it is
to pyrithiamine, and if so, to what extent.

The auto-

radiographic method was utilized to check the counting me
thod as to the brain's permeability to oxythiamine, and to
determine thiamine and oxythiamine localization, if any.
Both methods indicated the penetration of oxythia
mine into brain tissues, but further work must be done to
determine whether or not the amount is physiologically im
portant.
The results of the autoradiographic technique indi
cated the localization of thiamine in the gray matter of the
brain to a greater extent than in the white matter.

This

2
would indicate that the thiamine is more important around
the cell nuclei than it is in the fibers.

The autoradio

graphs indicated also that oxythiamine penetrated the brain
in lesser amounts than did thiamine, but localized in es
sentially the same areas.
These results suggest the need for a great deal more
work before the functions of thiamine and the effects of the
antagonists, oxythiamine and pyrithiamine can be fully
clarified.

